ESC 365 - Prognostic value of CHADSVASC score on mortality in patients referred for stress testing with and without atrial fibrillation

ESC Premium Access

Prognostic value of CHADSVASC score on mortality in patients referred for stress testing with and without atrial fibrillation

Session: Poster Session 1 - Atrial fibrillation - Stroke Prevention

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor S. Harb (Cleveland, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Serge Harb

Cleveland Clinic, Cleveland (United States of America)

0 follower

8 more presentations in this session

Temporal relations between atrial fibrillation and ischemic stroke and their prognostic impact on mortality

Speaker: Doctor S. Camen (Hamburg, DE)

Predictors of stroke and overall mortality in real world patients with atrial fibrillation treated with oral anticoagulants.

Speaker: Doctor M. Anguita Sanchez (Cordoba, ES)

Clinical Efficacy and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients with Non-Valvular Atrial Fibrillation: Results from a Nationwide Cohort Study

Speaker: Doctor M. Cho (Seoul, KR)

Effect of concomitant antiplatelet agents on clinical outcomes in the Edoxaban versus Warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial

Speaker: Professor A. Goette (Paderborn, DE)

The global ETNA-AF registry programme: snapshot baseline demographics and patient characteristics from more than 17,700 atrial fibrillation patients on edoxaban

Speaker: Doctor Y. Koretsune (Osaka, JP)

Access the full session

Poster Session 1 - Atrial fibrillation - Stroke Prevention

Speakers: Doctor S. Harb, Doctor S. Camen, Doctor M. Anguita Sanchez, Doctor M. Cho, Professor A. Goette...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources